GT-02037

N/A

Report date: 2022/12/26 12:27:34
NME

Base Information

Drug NameGT-02037
Drug Alias NameGT-02037
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGrowth hormone-releasing hormone receptor antagonistsSomatostatin receptor agonists
TargetsGrowth hormone-releasing hormone receptorSomatostatin receptor
Therapy Area/IndicationsAcromegaly
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesPharmaspur
China Registration ClassN/A

Develop Information

Active CompaniesPharmaspur
Inactive CompaniesN/A
Active IndicationsAcromegaly
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A